Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tom Gallen

Managing Editor, Europe

Tom reports and edits European consumer healthcare industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switch.

Latest From Tom Gallen

Haleon Invests In Healthcare Professionals With Centre for Human Sciences Launch

Haleon has established its Centre for Human Sciences to foster collaboration between academics in human behavior and frontline healthcare professionals. The consumer health giant hopes the initiative will help solve some of the most pressing challenges facing healthcare professionals.

OTC Drugs Business Strategies

High Proportion Of Supplements Sold Online In France Making Unlawful Claims

An investigation by the French General Directorate for Competition Policy, Consumer Affairs and Fraud Control found more than half of firms selling dietary supplements online were making unauthorized claims for their products.

France Dietary Supplements

Vision Healthcare Makes Probiotic Play With AixSwiss Acquisition

European dietary supplements online specialist Vision Healthcare has added the Nupure probiotics brand to its portfolio with the acquisition of Netherlands-based AixSwiss.

Europe Deals

EU Regulators Clarify Rules On Nasal Spray Claims Ahead Of Cold & Flu Season

The EU's medical device regulators have joined forces to remind consumer health firms of the rules which must be followed when marketing a nasal spray offering protection from viruses, such as influenza and SARS-CoV-2.

Europe OTC Devices

Sanofi Pulls Allevia 'Non-Drowsy' Claim Following MHRA Probe

Sanofi's claim in a TV ad that its Allevia hay fever tablets were non drowsy contradicted the drug's summary of product characteristics, found an investigation by the UK's Medicines and Healthcare products Regulatory Agency.

Ad Complaints OTC Drugs

Nestlé's Novel Iron Ingredient Judged Safe For Use In Europe

A new source of iron developed by Nestle has been granted a positive opinion as a novel food from the European Food Safety Authority.

Europe Wellness
See All